Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Change in Account Payables (2020 - 2026)

Aytu Biopharma has reported Change in Account Payables over the past 9 years, most recently at -$1.1 million for Q4 2025.

  • Quarterly Change in Account Payables rose 40.3% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$384000.0 through Dec 2025, down 116.59% year-over-year, with the annual reading at $287000.0 for FY2025, 113.82% up from the prior year.
  • Change in Account Payables was -$1.1 million for Q4 2025 at Aytu Biopharma, down from $1.7 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $6.6 million in Q4 2021 and troughed at -$9.9 million in Q3 2021.
  • The 5-year median for Change in Account Payables is $398000.0 (2025), against an average of -$186789.5.
  • Year-over-year, Change in Account Payables soared 375.51% in 2021 and then tumbled 1174.63% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $6.6 million in 2021, then crashed by 167.24% to -$4.4 million in 2022, then grew by 9.42% to -$4.0 million in 2023, then soared by 54.74% to -$1.8 million in 2024, then surged by 40.3% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Change in Account Payables are -$1.1 million (Q4 2025), $1.7 million (Q3 2025), and -$1.4 million (Q2 2025).